(2S,4R)-1-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

ID: ALA4228963

PubChem CID: 145986800

Max Phase: Preclinical

Molecular Formula: C24H29F3N4O4S

Molecular Weight: 526.58

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C24H29F3N4O4S/c1-13-18(36-12-29-13)15-7-5-14(6-8-15)10-28-20(33)17-9-16(32)11-31(17)21(34)19(23(2,3)4)30-22(35)24(25,26)27/h5-8,12,16-17,19,32H,9-11H2,1-4H3,(H,28,33)(H,30,35)/t16-,17+,19-/m1/s1

Standard InChI Key:  LDFHQQVQPPLUDX-ZIFCJYIRSA-N

Molfile:  

     RDKit          2D

 36 38  0  0  0  0  0  0  0  0999 V2000
    3.6042  -24.8627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8917  -24.4502    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.8907  -25.2735    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.7458  -23.6252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4625  -23.2168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7506  -22.8003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4625  -24.8627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1770  -24.4502    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7480  -24.4502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4625  -25.6877    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9305  -24.7806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4825  -24.1675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0700  -23.4530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2631  -23.6247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1043  -25.5871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4928  -26.1409    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8896  -25.8398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0634  -26.6464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8488  -26.8992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0206  -27.7039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8051  -27.9568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4176  -27.4027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2404  -26.5927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4561  -26.3436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2033  -27.6545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4605  -28.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2855  -28.4312    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.5372  -27.6454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8678  -27.1634    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.9785  -29.1041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0336  -24.8627    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4055  -22.6993    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3191  -24.4502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3191  -23.6252    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0336  -23.2127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6046  -25.6877    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  5  4  1  0
  4  6  1  0
  7  8  1  0
  7  9  1  0
  7 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  8  1  0
 11 15  1  1
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 22 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 25  1  0
 26 30  1  0
  9  4  1  1
  9 31  1  0
 13 32  1  6
 31 33  1  0
 33 34  2  0
  4 35  1  0
 33  1  1  0
  1 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4228963

    ---

Associated Targets(Human)

VHL Tchem Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 526.58Molecular Weight (Monoisotopic): 526.1862AlogP: 2.79#Rotatable Bonds: 6
Polar Surface Area: 111.63Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.12CX Basic pKa: 2.65CX LogP: 1.80CX LogD: 1.42
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.54Np Likeness Score: -0.58

References

1. Soares P, Gadd MS, Frost J, Galdeano C, Ellis L, Epemolu O, Rocha S, Read KD, Ciulli A..  (2018)  Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298).,  61  (2): [PMID:28853884] [10.1021/acs.jmedchem.7b00675]

Source